Qu Biologics Inc.
Records under this name other than the patents Qu Biologics Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 5 patents it holds.
Showing 1 to 9 of 9 · Back to Qu Biologics Inc.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,320,788 | Tissue targeted antigenic activation of the immune response to treat cancers Term ended Term ended Feb 15, 2026 · USPTO record | Term ended | Term ended Feb 15, 2026 | USPTO record |
| US 11,226,340 | Therapeutically triggering an innate immune response in a target tissue Lapsed on the fee record Ended Jan 18, 2026 · USPTO record | Lapsed on the fee record | Ended Jan 18, 2026 | USPTO record |
| US 9,320,787 | Tissue targeted antigenic activation of the immune response to treat cancers Term ended Term ended Jan 17, 2026 · USPTO record | Term ended | Term ended Jan 17, 2026 | USPTO record |
| US 8,034,359 | Tissue Targeted Antigenic Activation of the Immune Response to Cancers Term ended Term ended Dec 14, 2025 · High confidence | Term ended | Term ended Dec 14, 2025 | High confidence |
| US 10,130,692 | Immunogenic anti-inflammatory compositions Term ended Term ended Oct 8, 2025 · USPTO record | Term ended | Term ended Oct 8, 2025 | USPTO record |
| US 8,501,198 | Tissue Targeted Antigenic Activation of the Immune Response to Treat Cancers Lapsed on the fee record Ended Aug 6, 2025 · Medium confidence | Lapsed on the fee record | Ended Aug 6, 2025 | Medium confidence |
| US 9,107,864 | Tissue Targeted Antigenic Activation of the Immune Response to Treat Cancers Term ended Term ended May 30, 2025 · High confidence | Term ended | Term ended May 30, 2025 | High confidence |
| US 9,775,896 | Tissue Targeted Antigenic Activation of the Immune Response to Treat Cancers Term ended Term ended May 30, 2025 · High confidence | Term ended | Term ended May 30, 2025 | High confidence |
| US 10,086,066 | Tissue Targeted Antigenic Activation of the Immune Response to Treat Cancers Term ended Term ended May 30, 2025 · High confidence | Term ended | Term ended May 30, 2025 | High confidence |